Jackson Creek Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,190
Closed -$1.05M 373
2026
Q1
$1.05M Sell
2,190
-100
-4% -$51.2K 0.31% 160
2025
Q4
$1.29M Buy
+2,290
New +$1.3M 0.38% 142
2024
Q3
Sell
-2,930
Closed -$1.21M 334
2024
Q2
$1.21M Sell
2,930
-90
-3% -$35.6K 0.44% 59
2024
Q1
$1.22M Sell
3,020
-1,654
-35% -$582K 0.44% 62
2023
Q4
$1.43M Sell
4,674
-92
-2% -$24.8K 0.55% 16
2023
Q3
$1.15M Sell
4,766
-21
-0.4% -$5.37K 0.49% 27
2023
Q2
$1.15M Buy
4,787
+250
+6% +$51.9K 0.46% 38
2023
Q1
$853K Sell
4,537
-7
-0.2% -$1.45K 0.36% 138
2022
Q4
$965K Sell
4,544
-973
-18% -$194K 0.43% 56
2022
Q3
$867K Buy
+5,517
New +$880K 0.41% 91
2020
Q4
Sell
-6,681
Closed -$747K 335
2020
Q3
$747K Buy
+6,681
New +$773K 0.34% 152

Other funds holding MEDP

Jackson Creek Investment Advisors's MEDP Position: Q2 2026 in Review

Jackson Creek Investment Advisors sold out of Medpace (MEDP) in Q2 2026, closing a stake of 2,190 shares — an estimated $1.05M sold.

Jackson Creek Investment Advisors first reported a position in MEDP in Q3 2020 and held it in 11 quarters. The position peaked at $1.43M in Q4 2023. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Jackson Creek Investment Advisors reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 2,190 Medpace shares in Q2 2026, an estimated $1.05M.
  • Jackson Creek Investment Advisors first reported a position in Medpace in Q3 2020 and held it in 11 quarters.
  • Jackson Creek Investment Advisors's Medpace position peaked at $1.43M in Q4 2023.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.